The data revealed expression of MALAT1 was up-regulated in vitro and in vivo in NAFLD, and knockdown of MALAT1 suppressed FFA-induced lipid accumulation in hepatocytes. The gene discussed is MALAT1; the disease is metabolic dysfunction-associated steatotic liver disease.